Evidence map›Paper›PMID 37089670›Full record

ArticleJournal of acute medicine2023

High-Dose vs. Low-Dose Dexamethasone in Patients With COVID-19: A Cohort Study in Rural Central America.

Eleazar Montalvan-Sanchez, Diego Chambergo-Michilot, Aida A Rodriguez-Murillo, Alexandra E Brooks, Dairy Palacios-Argenal, Shery Rivera-Pineda, Jose Ordonez-Montes, Rosa Estevez-Ramirez, Adrian Riva-Moscoso, Dalton A Norwood and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of acute medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Eleazar Montalvan-SanchezIndiana University School of Medicine Department of Medicine Indianapolis, IN USA.
Diego Chambergo-MichilotUniversidad Cientifica del Sur Departamento de Medicina Lima Peru.
Aida A Rodriguez-MurilloUniversidad Nacional Autónoma de Honduras Departamento de Medicina Tegucigalpa Honduras.
Alexandra E BrooksIndiana University School of Medicine Department of Medicine Indianapolis, IN USA.
Dairy Palacios-ArgenalUniversidad Nacional Autónoma de Honduras Departamento de Medicina Tegucigalpa Honduras.
Shery Rivera-PinedaUniversidad Nacional Autónoma de Honduras Departamento de Medicina Tegucigalpa Honduras.
Jose Ordonez-MontesUniversidad Nacional Autónoma de Honduras Departamento de Medicina Tegucigalpa Honduras.
Rosa Estevez-RamirezUniversidad Nacional Autónoma de Honduras Departamento de Medicina Tegucigalpa Honduras.
Adrian Riva-MoscosoUniversidad Peruana de Ciencias Aplicadas Departamento de Medicina Surco Peru.
Dalton A NorwoodThe University of Alabama at Birmingham Department of Preventive Medicine Birmingham, AL USA.
Alex Calderon-RodriguezUniversidad Nacional Autónoma de Honduras Departamento de Medicina Tegucigalpa Honduras.
Elizabeth Pineda-SanMartinUniversidad Nacional Autónoma de Honduras Departamento de Medicina Tegucigalpa Honduras.
Roberto GironUniversidad Nacional Autónoma de Honduras Departamento de Medicina Tegucigalpa Honduras.
Luis Rivera-CorralesUniversidad Nacional Autónoma de Honduras Departamento de Medicina Tegucigalpa Honduras.
Balduino Carcamo-MurilloUniversidad Nacional Autónoma de Honduras Departamento de Medicina Tegucigalpa Honduras.
Orlando GarnerTexas Tech University Health Sciences Center Pulmonology and Critical Care Medicine Permian Basin, TX USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To compare the clinical outcomes of a low dose dexamethasone strategy vs. a high-dose dexamethasone strategy in hypoxemic COVID-19 patients. A retrospective observational study comparing low-dose (8 mg) and high-dose dexamethasone (24 mg) of COVID-19 patients admitted from September 1, 2020 to October 31, 2020 in a hospital in Honduras. We included 81 patients with confirmed COVID-19 who required oxygen therapy. The mean age was similar between groups (57.49 vs. 56.95 years). There were more male patients in the group of 24 mg (

Indexed as

cohortcorticosteroidsCOVID-19Latin AmericaLatinos or HispanicWestern Honduras

Identifiers

PMID37089670
PMCPMC10116034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.